Corvus Pharmaceuticals Stock Forecast - Market Facilitation Index

CRVS Stock  USD 8.69  0.87  9.10%   
Corvus Stock Forecast is based on your current time horizon.
  
Inventory Turnover is likely to drop to -0.6 in 2024. Payables Turnover is likely to drop to 0.09 in 2024. Common Stock Shares Outstanding is likely to drop to about 30.7 M in 2024. Net Loss is likely to drop to about (39 M) in 2024.
Corvus Pharmaceuticals has current Market Facilitation Index of 0. Market Facilitation Index is simply a difference between period high and low prices divided by period trading volume.
Check Corvus Pharmaceuticals VolatilityBacktest Corvus PharmaceuticalsInformation Ratio  

Corvus Pharmaceuticals Trading Date Momentum

On November 12 2024 Corvus Pharmaceuticals was traded for  8.69  at the closing time. The top price for the day was 9.70  and the lowest listed price was  8.67 . The trading volume for the day was 673.9 K. The trading history from November 12, 2024 did not affect price variability. The overall trading delta against the current closing price is 8.17% .
Market Facilitation Index was developed by Dr. Bill Williams. This indicator can help to determine either strong or week signal that can follow the current trend line by looking at how Market Facilitation index correlates with trading volume over time.
Compare Corvus Pharmaceuticals to competition

Other Forecasting Options for Corvus Pharmaceuticals

For every potential investor in Corvus, whether a beginner or expert, Corvus Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Corvus Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Corvus. Basic forecasting techniques help filter out the noise by identifying Corvus Pharmaceuticals' price trends.

Corvus Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Corvus Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Corvus Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Corvus Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Corvus Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Corvus Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Corvus Pharmaceuticals' current price.

Corvus Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Corvus Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Corvus Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Corvus Pharmaceuticals stock market strength indicators, traders can identify Corvus Pharmaceuticals entry and exit signals to maximize returns.

Corvus Pharmaceuticals Risk Indicators

The analysis of Corvus Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Corvus Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting corvus stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Corvus Stock Analysis

When running Corvus Pharmaceuticals' price analysis, check to measure Corvus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corvus Pharmaceuticals is operating at the current time. Most of Corvus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Corvus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corvus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Corvus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.